Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N02RS1 in Acute Bronchitis
NCT02637310Phase 2Completed
- Sponsor
- PharmaKing
- Start
- Dec 2015
- Primary completion
- Mar 2016
- Modality
- HM (Herbal Medicine)
01
Overview
Phase 2, randomised, double-blind trial in acute bronchitis comparing N02RS1 1200mg with Placebo (2 arms). Primary endpoint: Bronchitis Severity Score variation at 7 days. Started Dec 2015; status: completed.
02
Drugs
PMK-N02RS1
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT02637310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02637310.